GlassScriptPhysician profile
Nikola Dobrilovic
NPI 1649228776
$25,744.21
in general payments reported to CMS, 2019-2025
26 companies · $2,172 in 2025
The $2,172 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,687 · 2020: $2,522 · 2021: $433 · 2022: $15K · 2023: $3,192 · 2024: $480 · 2025: $2,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $2,844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $2,844.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,929.54 | 2022-2023 | Davinci Xi |
| Edwards Lifesciences Corporation | $3,902.71 | 2019-2025 | |
| Abiomed | $890.93 | 2023-2025 | Impella |
| Abbott Laboratories | $613.98 | 2021-2025 | Epic, Navitor |
| Atricure, INC. | $504.97 | 2019-2025 | Synergy Ablation System |
| Medtronic, INC. | $428.83 | 2021-2025 | Corevalve Evolut R, Vitalflow Console, Cardioblate Cryoflex |
| Livanova USA, INC. | $255.91 | 2019-2020 | |
| Corcym INC | $204.61 | 2024 | Perceval, Carbomedics Supra-Annular (Top Hat) |
| Getinge USA Sales, LLC | $195.19 | 2025 | Heartstring III Proximal Seal |
| Biostable Science & Engineering | $192.82 | 2022 | |
| Zimmer Biomet Holdings, INC. | $102.20 | 2019 | |
| La Jolla Pharmaceutical Company | $101.34 | 2025 | Giapreza |
| Fidia Pharma USA INC. | $65.62 | 2021 | |
| Pfizer INC. | $65.43 | 2025 | |
| Stryker Corporation | $55.13 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.39 | 2024 | Jardiance |
| Boston Scientific Corporation | $28.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.22 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $27.43 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.96 | 2022 | |
| Alnylam Pharmaceuticals INC. | $20.99 | 2025 | Onpattro |
| Irhythm Technologies, INC. | $19.16 | 2023 | Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $14.99 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.13 | 2022 | |
| Medtronic Vascular, INC. | $13.44 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikola Dobrilovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.